Penserra Capital Management LLC Viatris Inc Transaction History

Penserra Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $10,234 - $12,661	-1,167 Reduced 17.63%	5,452 $59,000
Q3 2023 Nov 15, 2023	SELL	$9.59 - $11.35 $10,385 - $12,292	-1,083 Reduced 14.06%	6,619 $65,000
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $69,472 - $79,253	7,702 New	7,702 $76,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.